What truly makes a PhD pathway in gene and cell therapy effective today?

This question opens the interview with Raffaella Di Micco, Professor and Scientific Coordinator of the RAREFIND Gene and Cell Therapy track, embedded within the National PhD Programme in Science and Technology for Advanced Therapies (PhD-STAT, IUSS Pavia).

In conversation with Graciana Diez Roux (RAREFIND Programme Coordinator), Raffaella Di Micco shares the vision behind RAREFIND: a PhD programme immersed in a real translational ecosystem, where research is not an end in itself but is designed to address unmet medical needs and deliver tangible impact for patients.

Within PhD-STAT, the RAREFIND Gene and Cell Therapy track stands out for:

• 🔬 Impact-driven research with a strong translational focus
• 🚀 Structured mentoring and career development
• 🌍 Mobility and secondments across a network of excellence including Fondazione Telethon, TIGEM, SR-Tiget and IUSS – Scuola Universitaria Superiore Pavia

The interview also provides practical advice for prospective applicants, offering insight into what it means to train today as a researcher in the field of advanced therapies.

👉 Read the full interview:
https://lnkd.in/dH6uNQYk